Barbara Stolz

[111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation

Willem H. Bakker, Rainer Albert, Christian Bruns et al. · Life Sciences · 1991 · 327 citations

Engineering, Oncologic Imaging, Potential Radiopharmaceutical +10

Antitumor Efficacy of Intermittent Treatment Schedules with the Rapamycin Derivative RAD001 Correlates with Prolonged Inactivation of Ribosomal Protein S6 Kinase 1 in Peripheral Blood Mononuclear Cells

Anne Boulay, Sabine Zumstein-Mecker, Christine Stephan et al. · Cancer Research · 2004 · 319 citations · Full text

Evidence for interactions between MotA and MotB, torque-generating elements of the flagellar motor of Escherichia coli

Barbara Stolz, Howard C. Berg · Journal of Bacteriology · 1991 · 149 citations · Full text

Amino Acids, Bacteriology, Molecular Biology +20

The somatostatin receptor-targeted radiotherapeutic [ 90 Y-DOTA- d Phe 1 ,Tyr 3 ]octreotide ( 90 Y-SMT 487) eradicates experimental rat pancreatic CA 20948 tumours

Barbara Stolz, Gisbert Weckbecker, Peter Smith‐Jones et al. · European Journal of Nuclear Medicine and Molecular Imaging · 1998 · 134 citations

Tumor Biology, Y-smt 487, Pancreatic Cancer +9

Gallium-67/gallium-68-[DFO]-octreotide--a potential radiopharmaceutical for PET imaging of somatostatin receptor-positive tumors: synthesis and radiolabeling in vitro and preliminary in vivo studies.

Peter Smith‐Jones, Barbara Stolz, Christian Bruns et al. · PubMed · 1994 · 127 citations